- Nexalin Technology ( NXL ) has priced it IPO of 2,315,000 units, to raise gross proceeds of ~$9.6M.
- The units consist of 2,315,000 shares of common stock and 2,315,000 accompanying warrants to purchase up to 2,315,000 shares of common stock.
- Each share of common stock is being sold together with one warrant, each to purchase one share of common stock with an exercise price of $4.15/share at a combined offering price of $4.15.
- Nexalin ( NXL ) has granted the underwriters a 45-day over-allotment option to purchase up to an additional 347,250 shares of common stock and/or warrants to purchase up to 345,250 shares of common stock.
- The shares and warrants are expected to begin trading on the Nasdaq Capital on Sep 20, 2022, under the symbols "NXL" and "NXLIW," respectively.
For further details see:
Medical device firms Nexalin prices ~$9.6M IPO